- Lobbying
- novo AND nordisk AND pharmaceuticals
Lobbying Arrangements Results for 'Novo Nordisk Pharmaceuticals'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details |
NOVO NORDISK PHARMACEUTICALS
|
McKenna Long & Aldridge LLP | |||
Details Follow-on Biologics |
Novo Nordisk Inc.
|
COVINGTON & BURLING LLP | |||
Details Issues related to Medicare and Medicaid reimbursement for pharmaceuticals. Coverage and reimbursement of obesity medications; S.595/H.R.1530, Treat and Reduce Obesity Act of 2019. General diabetes... |
Novo Nordisk Inc.
|
Thorn Run Partners | |||
Details Enforcement priorities and policies regarding communications by pharmaceutical and medical device manufacturers about their medical products. |
Medical Information Working Group
|
Ropes & Gray, LLP | |||
Details Preventative Health Savings Act (H.R. 2584/S. 1361) Drug importation, generally Issues related to the 340B Drug Pricing Program, generally H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Or... |
Novo Nordisk
|
Roberti Global (fka Roberti White, LLC) | |||
Details DOJ policy regarding off label communications. |
Medical Information Working Group
|
SIDLEY AUSTIN LLP | |||
Details H. Con. Res. 27, "Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025" S. Con. Res. 11/H... |
Novo Nordisk Pharmaceuticals, Inc.
|
SLC Health Strategies, LLC |